Additive effects of rapamycin and aspirin on dendritic cell allostimulatory capacity.

Details

Serval ID
serval:BIB_F4E32BE7E1F8
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Additive effects of rapamycin and aspirin on dendritic cell allostimulatory capacity.
Journal
Immunopharmacology and Immunotoxicology
Author(s)
Roehrich M.E., Wyss J.C., Kumar R., Pascual M., Golshayan D., Vassalli G.
ISSN
1532-2513 (Electronic)
ISSN-L
0892-3973
Publication state
Published
Issued date
2015
Peer-reviewed
Oui
Volume
37
Number
5
Pages
434-441
Language
english
Abstract
Acting as antigen presenting cells, mature dendritic cells (DCs) initiate both innate and adaptive alloimmune responses. However, immature DCs are weak immunostimulators and mediate tolerogenic effects under certain conditions. Tolerogenic activities of immature DCs can be enhanced by pharmacological agents. Here, we compared pharmacological DC preconditioning with rapamycin and aspirin, applied alone or in combination, on LPS-induced DC maturation and T-cell allostimulatory capacity. Preconditioning with aspirin but not rapamycin tended to reduce the number of mouse bone marrow-derived immature DCs expressing CD40 and major histocompatibility complex class II molecules upon LPS stimulation. Conversely, DC preconditioning with rapamycin, but not aspirin, reduced T-cell alloproliferative responses. A combination of rapamycin and aspirin was more effective than either drug applied alone with respect to inhibition of T-cell alloproliferation. The two agents in combination reduced numbers of CD4(+)IFN-γ(+) Th1 and CD4(+)IL-17(+) Th17 effector cells while maintaining Foxp3(+) regulatory T cells. These results suggest aspirin may moderately enhance rapamycin-mediated inhibition of DC allostimulatory capacity.
Pubmed
Create date
27/11/2015 13:13
Last modification date
20/08/2019 16:21
Usage data